Pulmonary hypertension in lymphangioleiomyomatosis: Hemodynamic characteristics in a series of 20 patients

V. Cottin, S. Harari, X. Jais, H. Mal, M. Reynaud-Gaubert, G. Prévot, R. Lazor, C. Taillé, S. Zeghmar, G. Simonneau, J. F. Cordier, M. Humbert, The GERM²O²P (Lyon, Clamart, Paris, Marseille, Toulouse, France; Milano, Italy)

Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Session: Clinical features of pulmonary hypertension
Session type: Thematic Poster Session
Number: 2328
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cottin, S. Harari, X. Jais, H. Mal, M. Reynaud-Gaubert, G. Prévot, R. Lazor, C. Taillé, S. Zeghmar, G. Simonneau, J. F. Cordier, M. Humbert, The GERM²O²P (Lyon, Clamart, Paris, Marseille, Toulouse, France; Milano, Italy). Pulmonary hypertension in lymphangioleiomyomatosis: Hemodynamic characteristics in a series of 20 patients. Eur Respir J 2011; 38: Suppl. 55, 2328

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients},
Source: Eur Respir J 2012; 40: 630-640
Year: 2012



Hemodynamic and clinical relevance of “borderline pulmonary hypertension“
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Characteristics and outcome of patients with pre-capillary pulmonary hypertension who were drained for tamponade: A monocentric study
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Hemodynamic and echocardiographic profile of pulmonary hypertension related to scleroderma
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

CPFE (combined pulmonary fibrosis and emphysema): A case series
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Correlation of right ventricular echocardiographic parameters with hemodynamic factors in pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different?
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Myocardial perfusion in patients with pulmonary hypertension of different etiology
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Pulmonary arterial hypertension in patients treated with interferon
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014

Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018